ATE196991T1 - Verfahren zur zubereitung von biologisch aktiven komponenten enthaltenden mikrospheren - Google Patents
Verfahren zur zubereitung von biologisch aktiven komponenten enthaltenden mikrospherenInfo
- Publication number
- ATE196991T1 ATE196991T1 AT92401433T AT92401433T ATE196991T1 AT E196991 T1 ATE196991 T1 AT E196991T1 AT 92401433 T AT92401433 T AT 92401433T AT 92401433 T AT92401433 T AT 92401433T AT E196991 T1 ATE196991 T1 AT E196991T1
- Authority
- AT
- Austria
- Prior art keywords
- biologically active
- active components
- microspheres containing
- containing biologically
- preparing microspheres
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITPD910102A IT1247472B (it) | 1991-05-31 | 1991-05-31 | Processo per la preparazione di microsfere contenenti componenti biologicamente attivi. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE196991T1 true ATE196991T1 (de) | 2000-11-15 |
Family
ID=11389598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92401433T ATE196991T1 (de) | 1991-05-31 | 1992-05-26 | Verfahren zur zubereitung von biologisch aktiven komponenten enthaltenden mikrospheren |
Country Status (9)
Country | Link |
---|---|
US (2) | US6066340A (de) |
EP (2) | EP0517565B1 (de) |
JP (1) | JPH07179363A (de) |
AT (1) | ATE196991T1 (de) |
CA (1) | CA2070095C (de) |
DE (1) | DE69231507T2 (de) |
ES (1) | ES2153355T3 (de) |
GR (1) | GR3034789T3 (de) |
IT (1) | IT1247472B (de) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9221329D0 (en) * | 1992-10-10 | 1992-11-25 | Delta Biotechnology Ltd | Preparation of further diagnostic agents |
IT1263144B (it) * | 1993-02-04 | 1996-08-01 | Lanfranco Callegaro | Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive |
JPH0827018A (ja) * | 1994-07-22 | 1996-01-30 | Sanwa Kagaku Kenkyusho Co Ltd | 生理活性ペプチド又は蛋白質を含有する薬剤組成物 |
DE69618938T2 (de) * | 1995-03-28 | 2002-10-31 | Fidia Advanced Biopolymers Srl | Nanosphären mit einem biokompatiblen polysaccharid |
KR100236771B1 (ko) * | 1997-04-01 | 2000-02-01 | 성재갑 | 히아루론산을 이용한 약물의 서방성 미세입자 제형 |
US7276251B2 (en) * | 1997-04-01 | 2007-10-02 | Lg Life Sciences, Ltd., Inc. | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
IT1294797B1 (it) | 1997-07-28 | 1999-04-15 | Fidia Advanced Biopolymers Srl | Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante |
WO1999059543A1 (en) | 1998-05-20 | 1999-11-25 | Highchem Company., Ltd. | A pharmaceutical formulation for nasal administration |
US6824793B1 (en) | 1998-06-01 | 2004-11-30 | Chiron Corporation | Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
WO1999062546A1 (en) * | 1998-06-01 | 1999-12-09 | Chiron Corporation | Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
PT1154793E (pt) | 1999-02-26 | 2010-12-21 | Novartis Vaccines & Diagnostic | Utilização de bioadesivos e adjuvantes para a administração de antigénios nas mucosas |
WO2000078358A2 (en) * | 1999-06-18 | 2000-12-28 | The Collaborative Group, Ltd. | Hyaluronic acid microspheres for sustained gene transfer |
US7582311B1 (en) * | 1999-10-15 | 2009-09-01 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
GB0004827D0 (en) * | 2000-02-29 | 2000-04-19 | Quadrant Holdings Cambridge | Compositions |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
DE10064219B9 (de) * | 2000-12-22 | 2009-02-12 | Nasalis Pain Relief International Gmbh | Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung |
US20050048126A1 (en) | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US6869617B2 (en) | 2000-12-22 | 2005-03-22 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
DE60218375D1 (de) * | 2001-03-30 | 2007-04-12 | Chisso Corp | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen |
FR2825273B1 (fr) * | 2001-05-29 | 2006-11-24 | Oreal | Composition pour le traitement des signes cutanes du vieillissement |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
BR0212833A (pt) | 2001-09-26 | 2004-10-13 | Baxter Int | Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida |
US7276254B2 (en) * | 2002-05-07 | 2007-10-02 | Xerox Corporation | Emulsion/aggregation polymeric microspheres for biomedical applications and methods of making same |
US20050287135A1 (en) * | 2002-05-17 | 2005-12-29 | Wyeth | Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
US20040197264A1 (en) * | 2003-04-04 | 2004-10-07 | Alexander Schwarz | Microspheres comprising therapeutic and diagnostic radioactive isotopes |
ES2226567B1 (es) * | 2003-06-20 | 2006-07-01 | Universidad De Santiago De Compostela | Nanoparticulas de acido hialuronico. |
ES2232287B1 (es) * | 2003-07-04 | 2006-11-01 | Advanced In Vitro Cell Technologies, S.L. | Nanoparticulas de derivados polioxietilenados. |
US8124120B2 (en) * | 2003-12-22 | 2012-02-28 | Anika Therapeutics, Inc. | Crosslinked hyaluronic acid compositions for tissue augmentation |
ES2246694B1 (es) * | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Nanoparticulas pegiladas. |
ES2246695B1 (es) * | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico. |
KR101502920B1 (ko) | 2005-06-21 | 2015-03-17 | 조마 (유에스) 엘엘씨 | IL-1β 결합성 항체 및 그의 단편 |
WO2008077145A2 (en) | 2006-12-20 | 2008-06-26 | Xoma Technology Ltd. | Treatment of il-1-beta related diseases |
US8747872B2 (en) | 2007-05-02 | 2014-06-10 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
AU2008343085B2 (en) | 2007-12-20 | 2015-03-12 | Xoma (Us) Llc | Methods for the treatment of gout |
ITMI20080981A1 (it) * | 2008-05-27 | 2009-11-28 | Fidia Advanced Biopolymers Srl | Processo per la preparazione di microsfere di polimeri semi-sintetici |
US20100092526A1 (en) | 2008-09-26 | 2010-04-15 | Nanobio Corporation | Nanoemulsion therapeutic compositions and methods of using the same |
WO2010057197A1 (en) | 2008-11-17 | 2010-05-20 | The Regents Of The University Of Michigan | Cancer vaccine compositions and methods of using the same |
CA2765511C (en) | 2009-06-16 | 2015-05-12 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
US8658603B2 (en) | 2010-06-16 | 2014-02-25 | The Regents Of The University Of Michigan | Compositions and methods for inducing an immune response |
GB201017889D0 (en) * | 2010-10-22 | 2010-12-01 | Univ Dublin | A polymeric nanoparticle |
WO2012092539A2 (en) | 2010-12-31 | 2012-07-05 | Takeda Pharmaceutical Company Limited | Antibodies to dll4 and uses thereof |
CN104144946A (zh) | 2011-12-19 | 2014-11-12 | 爱克索马美国有限责任公司 | 治疗痤疮的方法 |
EP2802603A4 (de) | 2012-01-09 | 2015-11-04 | Scripps Research Inst | Ultralange komplementaritätsbestimmungsbereiche und verwendungen davon |
EP3663314A1 (de) | 2012-01-09 | 2020-06-10 | The Scripps Research Institute | Humanisierte antikörper mit ultralangem cdr3s |
JP6373961B2 (ja) | 2013-03-13 | 2018-08-15 | バイオスフィア メディカル,インコーポレイテッド | ラジオアイソトープ結合微粒子の組成物及び結合方法 |
AU2014290361B2 (en) | 2013-07-18 | 2019-04-18 | Taurus Biosciences, Llc | Humanized antibodies with ultralong complementarity determining regions |
EP3022224A2 (de) | 2013-07-18 | 2016-05-25 | Fabrus, Inc. | Antikörper mit ultralangen komplementaritätsbestimmenden regionen |
US10286078B2 (en) | 2013-09-13 | 2019-05-14 | The California Institute For Biomedical Research | Modified therapeutic agents and compositions thereof |
CA2927543C (en) | 2013-10-15 | 2021-07-20 | The California Institute For Biomedical Research | Peptidic chimeric antigen receptor t cell switches and uses thereof |
ES2741308T3 (es) | 2013-10-15 | 2020-02-10 | Scripps Research Inst | Interruptores de células T con receptores de antígenos quiméricos y usos de los mismos |
CN105992770B (zh) | 2013-11-01 | 2021-06-25 | 奥斯陆大学 | 白蛋白的变体及其用途 |
US11452767B2 (en) | 2013-11-15 | 2022-09-27 | Oslo Universitetssykehus Hf | CTL peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof |
US10039809B2 (en) | 2013-12-18 | 2018-08-07 | The California Institute For Biomedical Research | Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof |
JP7158853B2 (ja) | 2014-10-10 | 2022-10-24 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | 対象における食物アレルギーまたは呼吸器アレルギーを処置するための、かつ上記対象の鼻腔内に投与するための免疫原性組成物 |
WO2016141320A2 (en) | 2015-03-05 | 2016-09-09 | Northwestern University | Non-neuroinvasive viruses and uses thereof |
US10800828B2 (en) | 2015-03-26 | 2020-10-13 | The Scripps Research Institute | Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer |
EP3283113A4 (de) | 2015-04-15 | 2018-12-05 | The California Institute for Biomedical Research | Optimierte pne-basierte chimäre t-zell-rezeptor-schalter und verwendungen davon |
US20190000928A1 (en) | 2015-06-17 | 2019-01-03 | The California Institute For Biomedical Research | Modified therapeutic agents and compositions thereof |
WO2016207730A1 (en) | 2015-06-22 | 2016-12-29 | The University Of Oslo | Targeting of vaccine antigen to an intracellular compartment |
CN105663052B (zh) * | 2016-02-05 | 2019-03-15 | 舒泰神(北京)生物制药股份有限公司 | 神经生长因子缓释微球制剂及其制备方法 |
WO2017201390A1 (en) | 2016-05-19 | 2017-11-23 | The Regents Of The University Of Michigan | Novel adjuvant compositions |
CN110267982B (zh) | 2016-10-19 | 2024-02-23 | 斯克利普斯研究所 | 具有人源化靶向部分和/或经过优化的嵌合抗原受体相互作用结构域的嵌合抗原受体效应细胞开关以及其用途 |
WO2018096396A1 (en) | 2016-11-22 | 2018-05-31 | University Of Oslo | Albumin variants and uses thereof |
EP3678698A1 (de) | 2017-09-07 | 2020-07-15 | University Of Oslo | Impfstoffmoleküle |
US20210069319A1 (en) | 2017-09-07 | 2021-03-11 | University Of Oslo | Vaccine molecules |
EP4013788A1 (de) | 2019-08-12 | 2022-06-22 | Purinomia Biotech, Inc. | Verfahren und zusammensetzungen zur förderung und verstärkung von t-zell-vermittelten immunantworten durch adcc-targeting von cd39-exprimierenden zellen |
JP2022554187A (ja) | 2019-10-24 | 2022-12-28 | ミノトール セラピューティクス インコーポレイテッド | キメラサイトカイン改変抗体およびその使用方法 |
KR102296304B1 (ko) | 2020-11-30 | 2021-09-01 | 조광용 | 고팽윤성 히알루론산 비드 겔 제조 방법 |
KR102366394B1 (ko) | 2021-01-05 | 2022-02-23 | 조광용 | 고팽윤성 히알루론산 비드 겔 |
WO2022207793A1 (en) | 2021-03-31 | 2022-10-06 | Vib Vzw | Vaccine compositions for trypanosomatids |
AU2022264339A1 (en) | 2021-04-28 | 2023-11-09 | Minotaur Therapeutics, Inc. | Humanized chimeric bovine antibodies and methods of use |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2750090A1 (de) * | 1976-11-19 | 1978-06-01 | Sandoz Ag | Neue verabreichungsformen fuer organische verbindungen |
JPS59163313A (ja) * | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
US4636524A (en) | 1984-12-06 | 1987-01-13 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
SE8501022L (sv) | 1985-03-01 | 1986-09-02 | Pharmacia Ab | Format alster och forfarande for dess framstellning |
US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
US4847091A (en) * | 1985-11-29 | 1989-07-11 | Fisons Plc | Pharmaceutical composition including sodium cromoglycate |
GB8601100D0 (en) * | 1986-01-17 | 1986-02-19 | Cosmas Damian Ltd | Drug delivery system |
US4946870A (en) * | 1986-06-06 | 1990-08-07 | Union Carbide Chemicals And Plastics Company Inc. | Delivery systems for pharmaceutical or therapeutic actives |
IT1203814B (it) | 1986-06-30 | 1989-02-23 | Fidia Farmaceutici | Esteri dell'acido alginico |
US4925673A (en) * | 1986-08-18 | 1990-05-15 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
JPH0725689B2 (ja) * | 1986-10-07 | 1995-03-22 | 中外製薬株式会社 | 顆粒球コロニ−刺激因子を含有する徐放性製剤 |
US5108759A (en) * | 1987-04-01 | 1992-04-28 | Ranney David F | Endothelial envelopment drug carriers |
US4883666A (en) * | 1987-04-29 | 1989-11-28 | Massachusetts Institute Of Technology | Controlled drug delivery system for treatment of neural disorders |
GB8712176D0 (en) * | 1987-05-22 | 1987-06-24 | Cosmas Damian Ltd | Drug delivery system |
GB8723846D0 (en) * | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
JP2670680B2 (ja) * | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
IT1219587B (it) | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
US5073543A (en) * | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
US5008116A (en) * | 1988-11-14 | 1991-04-16 | Frederick Cahn | Immunostimulatory microsphere |
JP3187410B2 (ja) * | 1989-08-10 | 2001-07-11 | 住友製薬株式会社 | 脳内投与用徐放性製剤 |
GB2237510B (en) * | 1989-11-04 | 1993-09-15 | Danbiosyst Uk | Small particle drug compositions for nasal administration |
US5707644A (en) * | 1989-11-04 | 1998-01-13 | Danbiosyst Uk Limited | Small particle compositions for intranasal drug delivery |
GB9202464D0 (en) * | 1992-02-05 | 1992-03-18 | Danbiosyst Uk | Composition for nasal administration |
US5879359A (en) * | 1992-08-03 | 1999-03-09 | Fidia S.P.A. | Biodegradable guide channels comprised of esters of hyaluronic acid for use in tissue repair as surgical aids |
IT1268955B1 (it) * | 1994-03-11 | 1997-03-18 | Fidia Advanced Biopolymers Srl | Esteri attivi di polisaccaridi carbossilici |
US5833891A (en) * | 1996-10-09 | 1998-11-10 | The University Of Kansas | Methods for a particle precipitation and coating using near-critical and supercritical antisolvents |
US5874029A (en) * | 1996-10-09 | 1999-02-23 | The University Of Kansas | Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent |
US5939323A (en) * | 1996-05-28 | 1999-08-17 | Brown University | Hyaluronan based biodegradable scaffolds for tissue repair |
-
1991
- 1991-05-31 IT ITPD910102A patent/IT1247472B/it active IP Right Grant
-
1992
- 1992-05-26 EP EP92401433A patent/EP0517565B1/de not_active Expired - Lifetime
- 1992-05-26 ES ES92401433T patent/ES2153355T3/es not_active Expired - Lifetime
- 1992-05-26 AT AT92401433T patent/ATE196991T1/de not_active IP Right Cessation
- 1992-05-26 EP EP99202579A patent/EP0979648A3/de not_active Withdrawn
- 1992-05-26 DE DE69231507T patent/DE69231507T2/de not_active Expired - Lifetime
- 1992-05-29 CA CA002070095A patent/CA2070095C/en not_active Expired - Lifetime
- 1992-05-29 JP JP4139012A patent/JPH07179363A/ja active Pending
-
1993
- 1993-12-20 US US08/169,558 patent/US6066340A/en not_active Expired - Lifetime
-
1999
- 1999-01-13 US US09/231,353 patent/US6039970A/en not_active Expired - Lifetime
-
2000
- 2000-11-08 GR GR20000402482T patent/GR3034789T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ITPD910102A0 (it) | 1991-05-31 |
EP0517565A3 (en) | 1992-12-30 |
JPH07179363A (ja) | 1995-07-18 |
EP0517565B1 (de) | 2000-10-18 |
DE69231507T2 (de) | 2001-05-03 |
CA2070095C (en) | 2000-04-25 |
ES2153355T3 (es) | 2001-03-01 |
IT1247472B (it) | 1994-12-17 |
DE69231507D1 (de) | 2000-11-23 |
GR3034789T3 (en) | 2001-02-28 |
EP0979648A2 (de) | 2000-02-16 |
ITPD910102A1 (it) | 1992-12-01 |
CA2070095A1 (en) | 1992-12-01 |
US6039970A (en) | 2000-03-21 |
US6066340A (en) | 2000-05-23 |
EP0979648A3 (de) | 2000-10-04 |
EP0517565A2 (de) | 1992-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE196991T1 (de) | Verfahren zur zubereitung von biologisch aktiven komponenten enthaltenden mikrospheren | |
DE59306546D1 (de) | Verfahren zur Herstellung von omega-Formylalkancarbonsäureestern | |
DE69422064D1 (de) | Verfahren zur Herstellung von optischaktiven 4-Halo-3-hydroxybuttersäure-Estern | |
DE69614174T2 (de) | Verfahren zur Herstellung von optisch-aktiven Gamma-substituierte-Hydroxy-Buttersäure-Ester | |
DE69015591T2 (de) | Verfahren zur Herstellung von Estern von ungesättigten Carbonsäuren. | |
ES2055209T3 (es) | Preparaciones conteniendo esteres del acido (met)acrilico que contienen grupos carbonamidas para su uso como componentes adhesivos para el tratamiento de materiales con colageno en medicina, asi como la fabricacion de estas preparaciones. | |
DE59104023D1 (de) | Verfahren zur Herstellung von monoethylenisch ungesättigten Carbonsäureestern. | |
DE69007599D1 (de) | Verfahren zur Racemisierung optisch aktiver Carbonsäureester. | |
DE59205000D1 (de) | Verfahren zur Herstellung von Hydroxyphenylcarbonsäureestern | |
DE69318642T2 (de) | Verfahren zur Herstellung von Carbonester Verfahren zur Herstellung von Carbonester | |
DE68913342D1 (de) | Verfahren zur Herstellung von Carbonsäureestern. | |
AU3674589A (en) | Skin- or hair-care compositions containing silica and carboxylic acid esters | |
DE68909305D1 (de) | Verfahren zur Herstellung von Carbonsäureestern. | |
DE69013490D1 (de) | Verfahren zur Herstellung von Estern von alpha-beta ungesättigten Karbonsäuren. | |
ITMI930337A1 (it) | Esteri di acidi carbossilici di idrossifenilalcanoli come agenti stabilizzanti | |
DE59403829D1 (de) | Verfahren zur Herstellung von Carbonsäurevinylestern | |
DE68914233T2 (de) | Verfahren zur Herstellung von Estern von Tricyclodekancarbonsäuren. | |
DE69207955T2 (de) | Verfahren zur Herstellung von Estern von racemierbaren Säuren | |
DE59303045D1 (de) | Verfahren zur Herstellung von Omega-(O-substituierten Urethano)alkylcarbonsäureestern | |
GR3007585T3 (de) | ||
ATE110720T1 (de) | Verfahren zur herstellung von 2-mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren ester. | |
DE59103279D1 (de) | Verfahren zur Herstellung von optisch aktiven aliphatischen Hydroxycarbonsäureestern. | |
DE59200649D1 (de) | Verfahren zur Herstellung optisch aktiver Carbonsäuren. | |
DE59204130D1 (de) | Verfahren zur Herstellung von Carbonsäureestern. | |
FR2701944B1 (fr) | Procédé d'hydroxycarbonylation de lactones en acides dicarboxyliques aliphatiques. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEFA | Change of the company name | ||
REN | Ceased due to non-payment of the annual fee |